T. S. Tracy

1.4k total citations
22 papers, 1.1k citations indexed

About

T. S. Tracy is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, T. S. Tracy has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 6 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in T. S. Tracy's work include Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (4 papers) and Analytical Chemistry and Chromatography (4 papers). T. S. Tracy is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Drug Transport and Resistance Mechanisms (4 papers) and Analytical Chemistry and Chromatography (4 papers). T. S. Tracy collaborates with scholars based in United States, Slovakia and Canada. T. S. Tracy's co-authors include Ken Korzekwa, Frank J. Gonzalez, Magang Shou, Robert A. Parise, Allan E. Rettie, Akiko Ogai, S D Hall, Melanie Johns Cupp, M J Hauer and J. Matthew Hutzler and has published in prestigious journals such as Blood, Biochemistry and Diabetes.

In The Last Decade

T. S. Tracy

22 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. S. Tracy United States	15	726	375	255	171	155	22	1.1k
Jan L. Wahlstrom United States	22	729 1.0×	354 0.9×	348 1.4×	99 0.6×	162 1.0×	47	1.3k
Imad Hanna United States	20	660 0.9×	520 1.4×	283 1.1×	117 0.7×	112 0.7×	30	1.1k
Raimund M. Peter United States	18	993 1.4×	425 1.1×	349 1.4×	164 1.0×	205 1.3×	21	1.5k
Tian J. Yang United States	15	721 1.0×	365 1.0×	314 1.2×	88 0.5×	125 0.8×	28	1.2k
Päivi Taavitsainen Finland	18	722 1.0×	318 0.8×	226 0.9×	77 0.5×	184 1.2×	26	1.1k
Takafumi Iwatsubo Japan	18	688 0.9×	524 1.4×	264 1.0×	115 0.7×	155 1.0×	33	1.2k
Martin K. Bayliss United Kingdom	18	613 0.8×	414 1.1×	344 1.3×	210 1.2×	113 0.7×	32	1.4k
Hayley S. Brown United Kingdom	12	772 1.1×	478 1.3×	295 1.2×	103 0.6×	80 0.5×	18	1.3k
Kirk R. Henne United States	18	769 1.1×	307 0.8×	392 1.5×	121 0.7×	136 0.9×	25	1.4k
Thomas F. Woolf United States	20	685 0.9×	389 1.0×	342 1.3×	93 0.5×	265 1.7×	44	1.4k

Countries citing papers authored by T. S. Tracy

Since Specialization

Citations

This map shows the geographic impact of T. S. Tracy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. S. Tracy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. S. Tracy more than expected).

Fields of papers citing papers by T. S. Tracy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. S. Tracy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. S. Tracy. The network helps show where T. S. Tracy may publish in the future.

Co-authorship network of co-authors of T. S. Tracy

This figure shows the co-authorship network connecting the top 25 collaborators of T. S. Tracy. A scholar is included among the top collaborators of T. S. Tracy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. S. Tracy. T. S. Tracy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Agrawal, Kriti, T. S. Tracy, Craig Hackett, et al.. (2025). Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody. Blood. 146(26). 3201–3212. 1 indexed citations

Luo, Jian, Rubén Rodríguez, Anne C. Hergarden, et al.. (2024). 771-P: Efficacy of CT-996, an Oral Small Molecule GLP-1 Receptor Agonist, in Human GLP-1 Receptor Knockin Mice and Obese Cynomolgus Monkeys. Diabetes. 73(Supplement_1). 1 indexed citations

Rodríguez, Rubén, et al.. (2023). 1649-P: Biased GLP-1 Improves Weight Loss with Additional Benefits on Glucose Homeostasis via Biased GIP in Diabetic Rodent Models. Diabetes. 72(Supplement_1). 1 indexed citations

Bostick, Christopher D., et al.. (2016). Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolism. Drug Metabolism and Disposition. 44(5). 741–749. 11 indexed citations

Tracy, T. S., Amarjit S. Chaudhry, Bhagwat Prasad, et al.. (2015). Interindividual Variability in Cytochrome P450–Mediated Drug Metabolism. Drug Metabolism and Disposition. 44(3). 343–351. 128 indexed citations

Lamba, Vishal, et al.. (2014). microRNA-34a is associated with expression of key hepatic transcription factors and cytochromes P450. Biochemical and Biophysical Research Communications. 445(2). 404–411. 41 indexed citations

Hodge, Lucy S., Mitchell E. Taub, & T. S. Tracy. (2011). Effect of its deaminated metabolite, 2′,2′-difluorodeoxyuridine, on the transport and toxicity of gemcitabine in HeLa cells. Biochemical Pharmacology. 81(7). 950–956. 22 indexed citations

Locuson, Charles W. & T. S. Tracy. (2007). Comparative modelling of the human UDP-glucuronosyltransferases: Insights into structure and mechanism. Xenobiotica. 37(2). 155–168. 33 indexed citations

Zgheib, Nathalie K., Reginald F. Frye, T. S. Tracy, Marjorie Romkes, & Robert A. Branch. (2006). Evaluation of flurbiprofen urinary ratios asin vivoindices for CYP2C9 activity. British Journal of Clinical Pharmacology. 63(4). 477–487. 20 indexed citations

10.

Tracy, T. S., et al.. (2001). Stability of Benzodiazepines in Formaldehyde Solutions. Journal of Analytical Toxicology. 25(3). 166–173. 26 indexed citations

11.

Gannett, Peter M., et al.. (2001). In Vitro Reaction of Barbiturates with Formaldehyde. Journal of Analytical Toxicology. 25(6). 443–449. 22 indexed citations

12.

Gannett, Peter M., et al.. (2001). In Vitro Reaction of Formaldehyde with Fenfluramine: Conversion to N-Methyl Fenfluramine. Journal of Analytical Toxicology. 25(2). 88–92. 22 indexed citations

13.

Zhang, Wei, et al.. (1999). Effect of protein-calorie malnutrition on cytochromes P450 and glutathione S-transferase. European Journal of Drug Metabolism and Pharmacokinetics. 24(2). 141–147. 21 indexed citations

14.

Brandšteterová, E., et al.. (1999). Achiral and chiral HPLC analysis of norverapamil and its metabolites in microsomal samples.. PubMed. 46(4). 207–11. 1 indexed citations

15.

Tracy, T. S., et al.. (1998). Reduction of the Human Placental Vascular Relaxation to Progesterone by Gestational Diabetes. PubMed. 8(1). 27–30. 7 indexed citations

16.

Cupp, Melanie Johns & T. S. Tracy. (1998). Cytochrome P450: new nomenclature and clinical implications.. PubMed. 57(1). 107–16. 81 indexed citations

17.

Korzekwa, Ken, Magang Shou, Akiko Ogai, et al.. (1998). Evaluation of Atypical Cytochrome P450 Kinetics with Two-Substrate Models: Evidence That Multiple Substrates Can Simultaneously Bind to Cytochrome P450 Active Sites. Biochemistry. 37(12). 4137–4147. 440 indexed citations

18.

Tracy, T. S., Christina M. Marra, Steven Wrighton, Frank J. Gonzalez, & Ken Korzekwa. (1997). Involvement of multiple cytochrome P450 isoforms in naproxen O-demethylation. European Journal of Clinical Pharmacology. 52(4). 293–298. 53 indexed citations

19.

Tracy, T. S., et al.. (1993). Metabolic inversion of (R)-ibuprofen. Formation of ibuprofenyl-coenzyme A.. Drug Metabolism and Disposition. 21(1). 114–120. 60 indexed citations

20.

Tracy, T. S. & S D Hall. (1992). Metabolic inversion of (R)-ibuprofen. Epimerization and hydrolysis of ibuprofenyl-coenzyme A.. Drug Metabolism and Disposition. 20(2). 322–327. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact